24–25 Nov 2026
IARC
Europe/Paris timezone

Stakeholder engagement to co-design a school-based delivery strategy for human papillomavirus (HPV) vaccination in Tamil Nadu, India

T3-8
25 Nov 2026, 15:15
10m
RC 150 - Auditorium (IARC)

RC 150 - Auditorium

IARC

25 avenue Tony Garnier, Lyon, France
Short oral Prevention Interventions, Policy & Public Health Impact Prevention Interventions, Policy & Public Health Impact

Speaker

Sathishrajaa Palaniraja (IARC)

Description

Introduction: Cervical cancer is the second most common cancer among women in India, contributing to one-fifth of the world's cervical cancer burden and one-quarter of related deaths. HPV vaccination of adolescent girls is the first pillar of the WHO cervical cancer elimination strategy. Population-level introduction in India has been gradual and operational evidence for school-based delivery at sub-national scale remains limited. Ahead of a pilot in four Tamil Nadu districts, we conducted an implementation study by employing a structured multi-sectoral stakeholder informed co-design approach to prioritise implementation strategies for school-based HPV vaccine introduction and to assess district readiness.
Methods: Building on formative research and national/global evidence synthesis, candidate strategies were generated at a facilitated one-day deliberative workshop engaging government directorates (health, immunisation, medical education, school education, and social welfare), professional bodies, technical partners and academia. Strategies were prioritised through dot voting and a Feasibility-Impact matrix, organised by implementation domain and mapped post hoc to Expert Recommendations for Implementing Change (ERIC) clusters. District readiness was assessed separately using the WHO HPV Vaccine Introduction Readiness Assessment Tool (2017).
Results: Stakeholders informed co-designed and prioritised recommendations included multi-channel pre-rollout IEC, school-based delivery for girls aged 9–14, integration into existing school health (RBSK) platforms, joint Health-Education planning, a uniform dosing schedule aligned with national/WHO guidance, structured pre-rollout planning with an adverse-event management protocol, frontline cadre sensitisation, school recognition, inclusion in the routine government programme, and deployment of trusted community workers. Readiness assessment across the four pilot districts confirmed strong political commitment, detailed microplanning, adequate cold-chain capacity, trained workforce and communication at launch.
Conclusions: A systematic, stakeholder-informed co-design produced a prioritised, context-adapted implementation strategy set and readiness appraisal for school-based HPV vaccination in Tamil Nadu. Co-design surfaced practical, intersectoral strategies incorporating equity considerations, and offers a replicable approach to inform HPV vaccine introduction and scale-up across Indian states and comparable low- and middle- income settings.
Keywords: HPV vaccine, Cervical cancer, Stakeholder-informed strategies, Prioritisation, School-based vaccination, India, Tamil Nadu.

Author

Co-authors

Dr Nandimandalam Venkata Vani (Department of Epidemiology, Biostatistics and Cancer Registry, Cancer Institute (WIA), Chennai, India) Dr Arunah Chandran (EPR branch, IARC) Dr Jayashree Natarajan (Department of Gynaecologic Oncology, Cancer Institute (WIA), Chennai, India) Dr Preetha Selvarajan (Department of Epidemiology, Biostatistics and Cancer Registry, Cancer Institute (WIA), Chennai, India) Dr Thrishya Rameshkumar (Department of Epidemiology, Biostatistics and Cancer Registry, Cancer Institute (WIA), Chennai, India) Dr Vinay Kumar Krishnamurthy (National Health Mission, Tamil Nadu) Dr Anavarathan Somasundaram (Directorate of Public Health and Preventive Medicine, Tamil Nadu) Dr Jerard Maria Selvam (Directorate of Public Health and Preventive Medicine, Tamil Nadu) Dr Rajaraman Swaminathan (Department of Epidemiology, Biostatistics and Cancer Registry, Cancer Institute (WIA), Chennai, India) Dr Sivaprakasam T Selvavinayagam (Directorate of Public Health and Preventive Medicine, Tamil Nadu) Dr Partha Basu (EPR branch, IARC)

Presentation materials

There are no materials yet.